The mechanism is that propofol can upregulate the expression level of miR-1-3p in CRC cells, thereby targeting insulin-like growth factor 1 (IGF1) and inhibiting the activation of the AKT/mTOR signaling axis [66]. This evidence concerns the gene MTOR and colorectal carcinoma.